Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iontophoresis Effects on Senses
NCT02487914Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jan 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lidocaine in pain (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Pain Threshold at 1 week. Started Jan 2013; status: completed.
02
Drugs
lidocaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT02487914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02487914.